Frontiers in Cellular and Infection Microbiology

Article	Citations
Antimicrobial Peptides: A New Hope in Biomedical and Pharmaceutical Fields	285
Role and Mechanism of Gut Microbiota in Human Disease	273
Antibiotic Resistance: One Health One World Outlook	270
Roseburia intestinalis: A Beneficial Gut Organism From the Discoveries in Genus and Species	225
Probiotic Gastrointestinal Transit and Colonization After Oral Administration: A Long Journey	200
The Gut Microbiota in Inflammatory Bowel Disease	189
The Female Vaginal Microbiome in Health and Bacterial Vaginosis	175
Periodontal Disease: The Good, The Bad, and The Unknown	163
SARS-COV-2 Variants: Differences and Potential of Immune Evasion	156
Cytokine Profiles Associated With Acute COVID-19 and Long COVID-19 Syndrome	134
Global Threat of Carbapenem-Resistant Gram-Negative Bacteria	133
Urinary Microbiome: Yin and Yang of the Urinary Tract	130
Wuhan to World: The COVID-19 Pandemic	125
Blood-Brain Barrier Disruption by Lipopolysaccharide and Sepsis-Associated Encephalopathy	119
Desulfovibrio Bacteria Are Associated With Parkinson’s Disease	116
Virulence Factors of Pseudomonas Aeruginosa and Antivirulence Strategies to Combat Its Drug Resistance	115
T-Helper Cell Subset Response Is a Determining Factor in COVID-19 Progression	113
The Role of Porphyromonas gingivalis Outer Membrane Vesicles in Periodontal Disease and Related Systemic Diseases	112
Understanding bacterial biofilms: From definition to treatment strategies	110
The Building Blocks of Antimicrobial Resistance in Pseudomonas aeruginosa: Implications for Current Resistance-Breaking Therapies	109
The Gut Microbiota (Microbiome) in Cardiovascular Disease and Its Therapeutic Regulation	108
Cathepsin L in COVID-19: From Pharmacological Evidences to Genetics	107
Gut Microbiota and Diarrhea: An Updated Review	107
Mechanism of the Gut Microbiota Colonization Resistance and Enteric Pathogen Infection	106
Effect of Fecal Microbiota Transplantation on Non-Alcoholic Fatty Liver Disease: A Randomized Clinical Trial	105

Impact of Gut Microbiota and Microbiota-Related Metabolites on Hyperlipidemia	104
Gut Microbiota: An Important Player in Type 2 Diabetes Mellitus	104
SARS-CoV-2 Infects Endothelial Cells In Vivo and In Vitro	102
Chitosan-Based Nanoparticles Against Viral Infections	101
Recent Advances in Molecular Diagnostics of Fungal Plant Pathogens: A Mini Review	100
Contribution of Lactobacillus iners to Vaginal Health and Diseases: A Systematic Review	97
Dysbiosis and Implication of the Gut Microbiota in Diabetic Retinopathy	91
Escherichia coli as a Multifaceted Pathogenic and Versatile Bacterium	90
Recent advances in recombinase polymerase amplification: Principle, advantages, disadvantages and applications	89
Viral Infections, the Microbiome, and Probiotics	88
Galleria mellonella as a Suitable Model of Bacterial Infection: Past, Present and Future	87
Gut Microbiota-Derived Metabolites in Irritable Bowel Syndrome	87
The Impact of Gut Microbiota on Radiation-Induced Enteritis	85
Application of Metagenomic Next-Generation Sequencing in the Diagnosis of Pulmonary Infectious Pathogens From Bronchoalveolar Lavage Samples	82
Herpes Simplex Virus Cell Entry Mechanisms: An Update	80
Brief Overview of Approaches and Challenges in New Antibiotic Development: A Focus On Drug Repurposing	76
Fecal Microbiota Transplantation Relieves Gastrointestinal and Autism Symptoms by Improving the Gut Microbiota in an Open-Label Study	76
Antimicrobial Activity of Lemongrass Essential Oil (Cymbopogon flexuosus) and Its Active Component Citral Against Dual-Species Biofilms of Staphylococcus aureus and Candida Species	74
Klebsiella pneumoniae Biofilms and Their Role in Disease Pathogenesis	74
Role of Gut Microbiome in Autism Spectrum Disorder and Its Therapeutic Regulation	74
Bacterial Vaginosis: What Do We Currently Know?	73
The Gut Microbiota of Critically Ill Patients With COVID-19	71
Clinical Experience of Personalized Phage Therapy Against Carbapenem-Resistant Acinetobacter baumannii Lung Infection in a Patient With Chronic Obstructive Pulmonary Disease	71
Mycobacterium abscessus complex: A Review of Recent Developments in an Emerging Pathogen	71
Antibiotic Resistance and Virulence Profiles of Klebsiella pneumoniae Strains Isolated From Different Clinical Sources	70
Oxidative Stress and Pathogenesis in Malaria	70
Bacteriocin-Producing Probiotic Lactic Acid Bacteria in Controlling Dysbiosis of the Gut Microbiota	69
Gut dysbiosis in nonalcoholic fatty liver disease: pathogenesis, diagnosis, and therapeutic implications	69
Coronavirus Disease (COVID-19) Caused by (SARS-CoV-2) Infections: A Real Challenge for Human Gut Microbiota	68
Colon Carcinogenesis: The Interplay Between Diet and Gut Microbiota	67
COVID-19 Pandemic and Vaccines Update on Challenges and Resolutions	67
Metabolic Implications of Oxidative Stress and Inflammatory Process in SARS-CoV-2 Pathogenesis: Therapeutic Potential of Natural Antioxidants	66
Cutaneous Malassezia: Commensal, Pathogen, or Protector?	66
Pulsatilla chinensis Saponins Ameliorate Inflammation and DSS-Induced Ulcerative Colitis in Rats by Regulating the Composition and Diversity of Intestinal Flora	66
Bipolaris sorokiniana-Induced Black Point, Common Root Rot, and Spot Blotch Diseases of Wheat: A Review	66
Breath Biopsy and Discovery of Exclusive Volatile Organic Compounds for Diagnosis of Infectious Diseases	65
Procedures for Fecal Microbiota Transplantation in Murine Microbiome Studies	64
CRISPR-Based COVID-19 Testing: Toward Next-Generation Point-of-Care Diagnostics	64
Nasopharyngeal Microbiome Signature in COVID-19 Positive Patients: Can We Definitively Get a Role to Fusobacterium periodonticum?	64
IgA Antibodies and IgA Deficiency in SARS-CoV-2 Infection	62
The Diagnostic Value of Metagenomic Next–Generation Sequencing in Lower Respiratory Tract Infection	62
Neuroinflammation, Sleep, and Circadian Rhythms	62
Elevated Plasma Fibrinogen Is Associated With Excessive Inflammation and Disease Severity in COVID-19 Patients	62
Specific Gut Microbiome and Serum Metabolome Changes in Lung Cancer Patients	61
Prophylactic and Therapeutic HPV Vaccines: Current Scenario and Perspectives	60
Long COVID: The Nature of Thrombotic Sequelae Determines the Necessity of Early Anticoagulation	60
Identification of Natural Inhibitors Against SARS-CoV-2 Drugable Targets Using Molecular Docking, Molecular Dynamics Simulation, and MM-PBSA Approach	60
RT-qPCR Assays for Rapid Detection of the N501Y, 69-70del, K417N, and E484K SARS-CoV-2 Mutations: A Screening Strategy to Identify Variants With Clinical Impact	60
Persistent Bacterial Coinfection of a COVID-19 Patient Caused by a Genetically Adapted Pseudomonas aeruginosa Chronic Colonizer	59
The Gut Microbiome and Metabolites Are Altered and Interrelated in Patients With Rheumatoid Arthritis	59

Improving Pulmonary Infection Diagnosis with Metagenomic Next Generation Sequencing	58
Alterations in Urobiome in Patients With Bladder Cancer and Implications for Clinical Outcome: A Single-Institution Study	58
A Pro-Inflammatory Gut Microbiome Characterizes SARS-CoV-2 Infected Patients and a Reduction in the Connectivity of an Anti-Inflammatory Bacterial Network Associates With Severe COVID-19	58
Acaricides Resistance in Ticks: Selection, Diagnosis, Mechanisms, and Mitigation	58
Azole Use in Agriculture, Horticulture, and Wood Preservation – Is It Indispensable?	58
The Human Skin Microbiome in Selected Cutaneous Diseases	58
Sugar-Coated Killer: Serotype 3 Pneumococcal Disease	58
Combination Therapies for Biofilm Inhibition and Eradication: A Comparative Review of Laboratory and Preclinical Studies	58
Extracellular Vesicles in Viral Infections: Two Sides of the Same Coin?	56
Gut Microbiota Exceeds Cervical Microbiota for Early Diagnosis of Endometriosis	55
Intracellular Porphyromonas gingivalis Promotes the Proliferation of Colorectal Cancer Cells via the MAPK/ERK Signaling Pathway	55
A Saliva-Based RNA Extraction-Free Workflow Integrated With Cas13a for SARS-CoV-2 Detection	54
Amylases: Biofilm Inducer or Biofilm Inhibitor?	54
Recurrent Urinary Tract Infection: A Mystery in Search of Better Model Systems	54
Mechanisms of Immunopathogenesis in Cutaneous Leishmaniasis And Post Kala-azar Dermal Leishmaniasis (PKDL)	54
Role of Cytokines in Experimental and Human Visceral Leishmaniasis	54
The Oral Microbiome in Periodontal Health	53
Review: The Emerging Role of Neutrophil Extracellular Traps in Sepsis and Sepsis-Associated Thrombosis	53
Virus-Induced Changes of the Respiratory Tract Environment Promote Secondary Infections With Streptococcus pneumoniae	52
Association Between Oral Microbiota and Cigarette Smoking in the Chinese Population	52
Impact of Age and Sex on COVID-19 Severity Assessed From Radiologic and Clinical Findings	52
The oral-gut axis: Salivary and fecal microbiome dysbiosis in patients with inflammatory bowel disease	52
The Vaginal Microbiome: A Long Urogenital Colonization Throughout Woman Life	52
The Role of Intestinal Dysbacteriosis Induced Arachidonic Acid Metabolism Disorder in Inflammaging in Atherosclerosis	51
One Year of SARS-CoV-2: Genomic Characterization of COVID-19 Outbreak in Qatar	51
Developing Recombinant Antibodies by Phage Display Against Infectious Diseases and Toxins for Diagnostics and Therapy	51
The Human Gut Phageome: Origins and Roles in the Human Gut Microbiome	50
Intestinal Microbiota Mediates High-Fructose and High-Fat Diets to Induce Chronic Intestinal Inflammation	50
Antimicrobial Peptides and Cell-Penetrating Peptides for Treating Intracellular Bacterial Infections	50
Exploration of Pattern Recognition Receptor Agonists as Candidate Adjuvants	50
Altered Fecal Microbiota Composition in Older Adults With Frailty	50
The Dynamic Roles of the Inner Membrane Complex in the Multiple Stages of the Malaria Parasite	50
The Role of Intestinal Bacteria and Gut–Brain Axis in Hepatic Encephalopathy	50
Secondary Bacterial Infection and Clinical Characteristics in Patients With COVID-19 Admitted to Two Intensive Care Units of an Academic Hospital in Iran During the First Wave of the Pandemic	49
Extracellular Vesicles in Trypanosomatids: Host Cell Communication	49
Effects of Berberine on the Gastrointestinal Microbiota	49
Revisiting ESKAPE Pathogens: virulence, resistance, and combating strategies focusing on quorum sensing	49
Drug resistant tuberculosis: Implications for transmission, diagnosis, and disease management	48
Review: Effect of Gut Microbiota and Its Metabolite SCFAs on Radiation-Induced Intestinal Injury	48
Gut Microbiota Composition in Prediabetes and Newly Diagnosed Type 2 Diabetes: A Systematic Review of Observational Studies	48
Salmonella Biofilm Formation, Chronic Infection, and Immunity Within the Intestine and Hepatobiliary Tract	48
Efficacy of Probiotics for Irritable Bowel Syndrome: A Systematic Review and Network Meta-Analysis	48
Tick Saliva and the Alpha-Gal Syndrome: Finding a Needle in a Haystack	48
Alterations of Gastric Microbiota in Gastric Cancer and Precancerous Stages	48
The Role of Tricarboxylic Acid Cycle Metabolites in Viral Infections	47
Vaginal Microbiome Composition in Early Pregnancy and Risk of Spontaneous Preterm and Early Term Birth Among African American Women	47
Salivary Microbiota for Gastric Cancer Prediction: An Exploratory Study	47
Immune Profile in Patients With COVID-19: Lymphocytes Exhaustion Markers in Relationship to Clinical Outcome	46
Gut microbiota remodeling: A promising therapeutic strategy to confront hyperuricemia and gout	46
Genomic Variations in the Structural Proteins of SARS-CoV-2 and Their Deleterious Impact on Pathogenesis: A Comparative Genomics Approach	46
Antimicrobial Peptides Human Beta-Defensin-2 and -3 Protect the Gut During Candida albicans Infections Enhancing the Intestinal Barrier Integrity: In Vitro Study	46
Bacteriophage Therapy for Staphylococcus Aureus Infections: A Review of Animal Models, Treatments, and Clinical Trials	46
Laboratory Diagnostic Tools for Syphilis: Current Status and Future Prospects	46
Dysbiosis of Gut Microbiota Is Associated With the Progression of Radiation-Induced Intestinal Injury and Is Alleviated by Oral Compound Probiotics in Mouse Model	46
Gut Microbiome Alterations in Patients With Visceral Obesity Based on Quantitative Computed Tomography	45
A Novel Acinetobacter baumannii Bacteriophage Endolysin LysAB54 With High Antibacterial Activity Against Multiple Gram-Negative Microbes	45
Low-Abundant Microorganisms: The Human Microbiome’s Dark Matter, a Scoping Review	45
Phages in the Gut Ecosystem	45
The CRISPR-Cas Mechanism for Adaptive Immunity and Alternate Bacterial Functions Fuels Diverse Biotechnologies	45
Synergism of Streptococcus mutans and Candida albicans Reinforces Biofilm Maturation and Acidogenicity in Saliva: An In Vitro Study	45
The Impact of ACE2 Polymorphisms on COVID-19 Disease: Susceptibility, Severity, and Therapy	45
The Skin Microbiome of Patients With Atopic Dermatitis Normalizes Gradually During Treatment	44
ACE2 Shedding and the Role in COVID-19	44
Wildlife and Antibiotic Resistance	44
Cathepsins in Bacteria-Macrophage Interaction: Defenders or Victims of Circumstance?	44
Bacillus amyloliquefaciens YN201732 Produces Lipopeptides With Promising Biocontrol Activity Against Fungal Pathogen Erysiphe cichoracearum	44
Diagnostic, Prognostic, and Therapeutic Roles of Gut Microbiota in COVID-19: A Comprehensive Systematic Review	44
Alteration of Gut Microbiome and Correlated Lipid Metabolism in Post-Stroke Depression	43
Role of Cell Surface Hydrophobicity in the Pathogenesis of Medically-Significant Fungi	43
Recent Advances in Research on Antibacterial Metals and Alloys as Implant Materials	43
The Relationship Between Pediatric Gut Microbiota and SARS-CoV-2 Infection	43
Survival and Control of Campylobacter in Poultry Production Environment	43
Immunometabolism of Macrophages in Bacterial Infections	43
Short-Chain Fatty Acid and FFAR2 Activation – A New Option for Treating Infections?	42
Clonal Candidemia Outbreak by Candida parapsilosis Carrying Y132F in Turkey: Evolution of a Persisting Challenge	42
Akkermansia muciniphila Protects Against Psychological Disorder-Induced Gut Microbiota-Mediated Colonic Mucosal Barrier Damage and Aggravation of Colitis	42
The role of probiotics in vaginal health	42
Washed Microbiota Transplantation Lowers Blood Pressure in Patients With Hypertension	42
Composition and diverse differences of intestinal microbiota in ulcerative colitis patients	42
Tuberculosis Drug Discovery: A Decade of Hit Assessment for Defined Targets	42

More Than Just a Periodontal Pathogen –the Research Progress on Fusobacterium nucleatum	42
Exosomes Derived From Alveolar Epithelial Cells Promote Alveolar Macrophage Activation Mediated by miR-92a-3p in Sepsis-Induced Acute Lung Injury	41
Deleterious Effects of SARS-CoV-2 Infection on Human Pancreatic Cells	41
Serological cross-reactivity among common flaviviruses	41
Overrepresentation of Enterobacteriaceae and Escherichia coli is the major gut microbiome signature in Crohn’s disease and ulcerative colitis; a comprehensive metagenomic analysis of IBDMDB datasets	41
High-Throughput Absolute Quantification Sequencing Revealed Osteoporosis-Related Gut Microbiota Alterations in Han Chinese Elderly	41
Outer membrane vesicles of Porphyromonas gingivalis trigger NLRP3 inflammasome and induce neuroinflammation, tau phosphorylation, and memory dysfunction in mice	41
Bacteriophage Cocktails Protect Dairy Cows Against Mastitis Caused By Drug Resistant Escherichia coli Infection	41
Factors Associated With MALDI-TOF Mass Spectral Quality of Species Identification in Clinical Routine Diagnostics	41
Prevalence of Fungal and Bacterial Co-Infection in Pulmonary Fungal Infections: A Metagenomic Next Generation Sequencing-Based Study	41
Structure and Function of Oral Microbial Community in Periodontitis Based on Integrated Data	41
Global epidemiology, genetic environment, risk factors and therapeutic prospects of mcr genes: A current and emerging update	40
A comprehensive review of the application of probiotics and postbiotics in oral health	40
Carbapenem-Resistant Enterobacterales in Long-Term Care Facilities: A Global and Narrative Review	40
Drug Resistance and Novel Therapeutic Approaches in Invasive Candidiasis	40
Vaginal Microbiota and Cytokine Levels Predict Preterm Delivery in Asian Women	40
High-fiber diet ameliorates gut microbiota, serum metabolism and emotional mood in type 2 diabetes patients	40
Revisiting Campylobacter jejuni Virulence and Fitness Factors: Role in Sensing, Adapting, and Competing	40
Gut Microbiota, Glucose, Lipid, and Water-Electrolyte Metabolism in Children With Nonalcoholic Fatty Liver Disease	40
Bacterial and Host Determinants of Group B Streptococcal Vaginal Colonization and Ascending Infection in Pregnancy	40
Roles of Gut Microbiota in the Regulation of Hippocampal Plasticity, Inflammation, and Hippocampus-Dependent Behaviors	40
Toxoplasma gondii Genotyping: A Closer Look Into Europe	40
Curcumin-driven reprogramming of the gut microbiota and metabolome ameliorates motor deficits and neuroinflammation in a mouse model of Parkinson’s disease	39
Taxonomic Characterization and Short-Chain Fatty Acids Production of the Obese Microbiota	39
Reverse Transcription Recombinase-Aided Amplification Assay With Lateral Flow Dipstick Assay for Rapid Detection of 2019 Novel Coronavirus	39
Forensic Analysis of Human Microbiome in Skin and Body Fluids Based on Geographic Location	39
Next-Generation Sequencing Reveals the Progression of COVID-19	39
The Role of Non-Typeable Haemophilus influenzae Biofilms in Chronic Obstructive Pulmonary Disease	38
Revisiting the Mechanisms of Immune Evasion Employed by Human Parasites	38
Analytical and Clinical Evaluation of “AccuPower SARS-CoV-2 Multiplex RT-PCR kit (Bioneer, South Korea)” and “Allplex 2019-nCoV Assay (Seegene, South Korea)” for SARS-CoV-2 RT-PCR Diagnosis: Korean CD	38
Molecular Mechanisms of Staphylococcus and Pseudomonas Interactions in Cystic Fibrosis	38
Comparison of Blood Bacterial Communities in Periodontal Health and Periodontal Disease	38
Gut Dysbiosis and Intestinal Barrier Dysfunction: Potential Explanation for Early-Onset Colorectal Cancer	38
Heterogeneous Klebsiella pneumoniae Co-infections Complicate Personalized Bacteriophage Therapy	37
Maternal obesity and the impact of associated early-life inflammation on long-term health of offspring	37
The Development of Ovine Gastric and Intestinal Organoids for Studying Ruminant Host-Pathogen Interactions	37
The Gut Microbiome Is Associated With Therapeutic Responses and Toxicities of Neoadjuvant Chemoradiotherapy in Rectal Cancer Patients—A Pilot Study	37
The Role of Neutrophil Extracellular Traps in Periodontitis	37
The Macrophage Response to Mycobacterium tuberculosis and Opportunities for Autophagy Inducing Nanomedicines for Tuberculosis Therapy	37
Aerobactin Seems To Be a Promising Marker Compared With Unstable RmpA2 for the Identification of Hypervirulent Carbapenem-Resistant Klebsiella pneumoniae: In Silico and In Vitro Evidence	37
Mucus and Mucins: The Underappreciated Host Defence System	37
Virulence and Antibiotic Resistance Characteristics of Vibrio Isolates From Rustic Environmental Freshwaters	37
SARS-CoV-2-Indigenous Microbiota Nexus: Does Gut Microbiota Contribute to Inflammation and Disease Severity in COVID-19?	37
A Predictive Model Based on the Gut Microbiota Improves the Diagnostic Effect in Patients With Cholangiocarcinoma	36
Distribution, Prevalence, and Causative Agents of Fungal Keratitis: A Systematic Review and Meta-Analysis (1990 to 2020)	36
A Strong Decline in the Incidence of Childhood Otitis Media During the COVID-19 Pandemic in the Netherlands	36
Review: The Role of Intestinal Dysbiosis in Parkinson’s Disease	36
Prevalence, Serotype Distribution and Antimicrobial Resistance of Non-Typhoidal Salmonella in Hospitalized Patients in Conghua District of Guangzhou, China	36
Infections and Pregnancy: Effects on Maternal and Child Health	36
Gut Microbiota Mediates the Preventive Effects of Dietary Capsaicin Against Depression-Like Behavior Induced by Lipopolysaccharide in Mice	36
The Complex Interactions Between Rotavirus and the Gut Microbiota	36
COVID-19 Vaccination in Pregnancy and Lactation: Current Research and Gaps in Understanding	36
Metagenomic Next-Generation Sequencing for Pathogenic Diagnosis and Antibiotic Management of Severe Community-Acquired Pneumonia in Immunocompromised Adults	36
The Roles of TRIMs in Antiviral Innate Immune Signaling	36
16S rDNA Full-Length Assembly Sequencing Technology Analysis of Intestinal Microbiome in Polycystic Ovary Syndrome	36
SARS-CoV-2: Emergence of New Variants and Effectiveness of Vaccines	35
The Role of Neutrophils and Neutrophil Elastase in Pneumococcal Pneumonia	35
Changes in the Cystic Fibrosis Airway Microbiome in Response to CFTR Modulator Therapy	35
Fecal Microbiota Transplantation Protects the Intestinal Mucosal Barrier by Reconstructing the Gut Microbiota in a Murine Model of Sepsis	35
Comparison of the Diagnostic Performance of qPCR, Sanger Sequencing, and Whole-Genome Sequencing in Determining Clarithromycin and Levofloxacin Resistance in Helicobacter pylori	35
Microbiota-Host-Irinotecan Axis: A New Insight Toward Irinotecan Chemotherapy	35
Analysis of Salivary Mycobiome in a Cohort of Oral Squamous Cell Carcinoma Patients From Sudan Identifies Higher Salivary Carriage of Malassezia as an Independent and Favorable Predictor of Overall Su	35
KAP1/TRIM28: Transcriptional Activator and/or Repressor of Viral and Cellular Programs?	35
Rapid Detection of Enterocytozoon hepatopenaei Infection in Shrimp With a Real-Time Isothermal Recombinase Polymerase Amplification Assay	35
Phage Endolysin LysP108 Showed Promising Antibacterial Potential Against Methicillin-resistant Staphylococcus aureus	35
Prospective Study Reveals Host Microbial Determinants of Clinical Response to Fecal Microbiota Transplant Therapy in Type 2 Diabetes Patients	35
COVID-19: Molecular and Cellular Response	35
Akkermansia muciniphila Exerts Strain-Specific Effects on DSS-Induced Ulcerative Colitis in Mice	34
The reservoir of latent HIV	34
Mechanisms by Which Traditional Chinese Medicines Influence the Intestinal Flora and Intestinal Barrier	34
Role of Immunity and Vaginal Microbiome in Clearance and Persistence of Human Papillomavirus Infection	34
No Evidence for Human Monocyte-Derived Macrophage Infection and Antibody-Mediated Enhancement of SARS-CoV-2 Infection	34
The Role of Probiotics in Alleviating Postweaning Diarrhea in Piglets From the Perspective of Intestinal Barriers	34
Global epidemiology of campylobacteriosis and the impact of COVID-19	34
Ibrexafungerp, a Novel Oral Triterpenoid Antifungal in Development: Overview of Antifungal Activity Against Candida glabrata	34
From Genes to Transcripts, a Tightly Regulated Journey in Plasmodium	34
Antifungal Pipeline	33
Clinical Predictors of COVID-19 Severity and Mortality: A Perspective	33
Supplementation With Chinese Medicinal Plant Extracts From Lonicera hypoglauca and Scutellaria baicalensis Mitigates Colonic Inflammation by Regulating Oxidative Stress and Gut Microbiota in a Colitis	33
Direct Detection and Identification of the Most Common Bacteria and Fungi Causing Otitis Externa by a Stepwise Multiplex PCR	33
Efficacy of Fecal Microbiota Transplantation in Irritable Bowel Syndrome: A Meta-Analysis of Randomized Controlled Trials	33
NS1: A Key Protein in the “Game” Between Influenza A Virus and Host in Innate Immunity	33
The Modular Circuitry of Apicomplexan Cell Division Plasticity	33
Gut Microbiome Dysbiosis in Alcoholism: Consequences for Health and Recovery	33
Subinhibitory Concentrations of Biogenic Silver Nanoparticles Affect Motility and Biofilm Formation in Pseudomonas aeruginosa	33
Comparison of Red-Complex Bacteria Between Saliva and Subgingival Plaque of Periodontitis Patients: A Systematic Review and Meta-Analysis	33
Phylogenetic Group Distribution of Uropathogenic Escherichia coli and Related Antimicrobial Resistance Pattern: A Meta-Analysis and Systematic Review	33
Bacterial extracellular vesicles and their novel therapeutic applications in health and cancer	33
Streptococcus, the Predominant Bacterium to Predict the Severity of Liver Injury in Alcoholic Liver Disease	32
Gut Microbiotic Features Aiding the Diagnosis of Acute Ischemic Stroke	32
Encapsulated Fecal Microbiota Transplantation: Development, Efficacy, and Clinical Application	32
Metagenome Analysis of Intestinal Bacteria in Healthy People, Patients With Inflammatory Bowel Disease and Colorectal Cancer	32
Dengue Virus Dysregulates Master Transcription Factors and PI3K/AKT/mTOR Signaling Pathway in Megakaryocytes	32
Differential Antibody Response to Inactivated COVID-19 Vaccines in Healthy Subjects	32
Review on Stress Tolerance in Campylobacter jejuni	32